Note : Les descriptions sont présentées dans la langue officielle dans laquelle elles ont été soumises.
X-5910 -1-
Functionally Independent Cloning Vectors
For Use In Streptomyces
The present invention relates to novel re-
combinant DNA cloning vectors comprising a functionally
independent origin of replication containing restric-
tion fragment of plasmid pEL7 and one or more DNA
segments that confer resistance to antibiotics. The
invention further relates to transformants of the
aforementioned vecto~s.
The present invention is related generaily to
the pairs o~ recombina~t DNA cloning vectors disclosed
in Canadian Patent No. 1,185,547 of W.M. Nakatsukasa, J.T.
Fayerman and J.A. Mabe, ~ranted April 16, 1985. The afore-
mentioned pairs of vectors co~prise plasmid pEL7 and a second
lS plasmid which is functionally dependent on plasmid pEL7 and
which comprises a restriction fragment of pEL7 and one or more
DNA seg~lents that confer resistance to antibiotics.
The vectors are readily distinguishable both struc
turally and also in that they are not functionally
20 dependent and thus do not require the presence of
plasmid pEL7 for replication and expression of anti-
biotic resistance.
The antibiotic resistance-conferring cloning
vectors are for use in Streptomyces and related host
25 cells. Hexetofore, the development and exploitation of
recombinant DNA technology in the above organisms has
been retarded and made especially difficult because of
the general lack of selectable genetic markers on
cloning vectors. The vectors to which the present
30 invention relates are functionally independent and
. ~i
.
62~
~-5910 -2-
selectable in both Streptomyces and other host st~:ains
and therefore represent a significant advance in the
technical art.
The vectors are particularly useful because
they are functionally independent, small, versatile and
can be transformed and selected in any Streptomyces
cell that is sensitive to an antibiotic for which
resistance is conveyed. Since over half of the clini-
cally important antibiotics are produced by Strepto-
10 myces strains, it is desirable to develop functionallyindependent cloning systems and vectors that are appli-
cable to that industrially important group. The pres-
ent invention provides such vectors and thus allows for
the cloning of genes into Streptomycès both for in-
lS creasing the yields of known antibiotics as well asfor the production of new antibiotics and antibiotic
derivatives.
The vectors provide vehicles for cloning DNA
into Streptomyces host cells and also allow for the
20 convenient selection of transormants. Since trans-
formation is a very low frequency event, such a func-
tional test is a practical necessity for determining
which cell(s), of among the millions of cells, has
acquired the plasmid DNA. This is important because
25 DNA sequences that are non-selectable can be inserted
onto the vectors and, upon transformation, cells con-
taining the vector and the particular DNA sequence of
interest can be isolated by appropriate antibiotic
selection.
For purposes of the present invention as
disclosed and claimed herein, the follcwing terms are
as defined below.
~a2~1~;2~9
X-5910 3
Recombinant DNA Cloniny Vector - any auto-
nomously replicating agent, including but not limited
to plasmids, comprising a DNA molecule to which one or
more additional DNA segments can or have been added.
Transformation - the introduction of DNA into
a recipient host cell that changes the genotype and
consequently results in a change in the recipient cell.
Transformant - a rscipient host cell that has
undergone transformation.
Functionally Dependent - the condition where-
upon plasmid replication and expression of resistance
to one or more antibiotics in a host cell requires the
presence of a separate and different plasmid.
Functionally Independent - the condition
lS whereupon plasmid replication and expression of resis-
tance to one or more antibiotics in a host cell occurs
in the absence of a separate and different plasmid.
Sensitive Host Cell - a host cell that cannot
grow in the presence of a given antibiotic without a
20 DNA segment that confers resistance thereto.
Restriction Fragment - any linear portion or
whole of plasmid or chromosomal DNA generated by the
action vf one or more restriction enzymes.
Insertional Isomer - one of the two or more
25 possible recombinant DNA molecules formed when a DNA
fragment is inserted at one of two or more compatible
sites on the recipient DNA.
Plasmid pLR2 ~1.6 kb BamHI Res-triction Frag-
ment - substantially the same ~1.6 ~b BamHI thiostrep-
30 ton resistance-conrerring fragment contained in plasmid
pIJ6.
X5910
Plasmid pLRl or pLR4 ~3.4 kb B HI Restric-
tion Fragment - the same ~3.4 kb BamHI neomycin resis-
tance-conferring fragment contained in plasmid pIJ2.
AmpR _ the ampicillin resistant phenotype.
Te~ - the tetracycline sensltive phenotype.
ThioR - the thiostrepton resis~ant phenot~pe.
~eo - the neomyci~. resistant phenotype.
In the accompanying drawings:
Figure l is a res triction site map of plasmid
pEL7;
Figure 2 is a restriction site map of plasmids
pLRl, pLR2 and pLR4;
Fic~ure 3 is a restriction site map of plasmids
pNM702A, pNM702B, pN~1704A and pNM704B;
Figure 4 is a restriction site map of plasmids
pNM705A, pNM705B, pNM703A, and pNM703B;
Figure 5 is a restriction site map Of plasmids
pNM706A, pNM706B, pNM707A and pNM707B; and
Figure 6 is a restriction site map of plasmids
pNM708A and pNM708B.
Detailed Description of the Invention
The present invention, in one aspect, resides in
a functionally independent recombinant DNA cloning vector
comprising:
a) a functional replicon-containing restriction
fragment of plasmid pEL7 and
b) one or more DNA segments that confer resistance
to at least one antibiotic when transformed
into a sensitive host cell,
c~ if desired, a replicon that is functional in
_. coli and a DNA segment that confers anti-
biotic resistance in a sensitive E. coli host
cell, said host cells being susceptible to
transformlation, cell division, and culture.
- 4a
X-5910
The present invention, in another aspect,
provides a process for preparing a functionally
independent recombinant DNA cloning vector which
comprises ligating
a) a functional replicon-containing restriction
fragment of plasmid pEL7 to
b) one or more DNA segments that confer resis-
tance to at least one antibiotic when t ans-
formed into a sensitive host cell and
c) if desired, to a restriction fragment which
comprises a replicon that i5 functional in E.
coli and a DNA segment that confers anti-
biotic resistance in a sensitive E. coli host
cell, said host cells being susceptible to
t~ansformation, cell division, and culture.
The invention further provides transformants
of the vectors prepared by the process of the invention.
Plasmid pEL7, from which replicon-containing
fragments are constructed, is ~10.9 kb and contains
several restriction sites which are advantageous for
molecular cloning. Since the replicon of plasmid pEL7
has been localized to within the ~6.78 kb BclI restric-
tion fragment, a variety of different replicon-contaln-
, . .
~2~
~-5910 -5-
ing fragments can be generated by digesting the plasmid
with restriction enzymes that cut outside the ~6.78 kb
BclI region. A detailed restriction site map of plas-
mid pEL7 is presented in Figure 1 of the accompanying
5 'drawings. For purposes of the present application,
Figure 1 and all subsequent figures are not drawn to
scale.
Plasmid pEL7 can be conventionally isolated
from Streptomyces ambofaciens/pEL7, a strain deposited
10 and made part of the permanent stock culture collection
of the Northern Regional Research Laboratory, Peoria,
Illinois, under the accession number NRRL 12523. It is
available to the public as a preferred source and stock
reservoir of the plasmid.
Although many different origin of replica-
tion-containing fragments of plasmid pEL7 can be con-
structed, the ~6.78 kb BclI restriction fragment is
exemplified herein for illustrative purposes. This
fragment can be independently ligated to one or more
20 antibiotic resistance-conferring DNA segments, exem-
plified herein by the thiostrepton resistance confer-
xing ~1.6 kb BamHI or 3 . 8 kb BclI restriction fragment
of plasmid pLR2, -the neomycin resistance-conferring
~3.4 kb BamHI restriction fragment of plasmid pLRl or
25 plasmid pLR4 and the ~2.8 kb SalI fragment of plasmid
pIJ43, to form functionally independent vectors illus
trative of the present invention.
Plasmid pLR2, the source of the thiostrepton
resistance-conferring fragment~ is ~18.7 kb and is
30 constructed by ligating HindIII-treated plasmid pIJ6~
disclosed in Thompson et al., 1980, Nature 286:525, to
HindIII-treated plasmid pBR322. Plasmid pLRl, the
,.
62~
X-59]0 -6-
source of the neomycin resistance-conferring ragment,
is ~14.8 kb and is similarly constructed except that
plasmid pIJ2, disclose~ in Thompson et al., 1980, is
substituted for plasmid pIJ6. An analogous construc-
tion, resulting in plasmid pLR4, is made by ligatingBamHI-treated plasmid pBR322 to B HI-treated plasmid
pLRl. Plasmids pLR2, pLRl and pLR4 are functional in
E. coli arld therefore can be amplified and isolated
conveniently for subsequent manipulation.
Plasmid pIJ43, the source of the erythromycin
resistance-conferring fragment, can be obtained from E.
coli 803/pIJ43, a strain deposited and made part of the
permanent stock culture collection of the American Type
culture Collec-tion, Rockville, Maryland. It is avail-
15 able to the public as a preferred source and stock
reservoir of the plasmid under the accession number
ATCC 39156. A restriction site and functional map of
each of plasmids pLRl, pLR2 and pLR4 is presented in
Figure 2 of the accompanying drawings.
For convenience and ease of construction, the
thiostrepton resistance-conferring ~1.6 kb BamHI or ~. 8
kb BclI fragment, the neomycin resistance-conferring
~3.4 kb BamHI fragment and the erythromycin resistance-
conferring ~2. 8 kb S_ I fragment are independently li-
25 gated to the ~6.78 kb origin of replication-containing
BclI fragment o~ plasmid pEL7. The resultincJ recombi-
nant DNA is then self ligated to produce functionally
independent plasmids illustrative of the present inven-
tion. Recombinant plasmids of two orientations result
30 depending upon the orientation of the particular resis-
tance-conerring DNA fragment. Thus, ligation of the
6Z~
X-5910 7
~1.6 kb BamHI fragment of plasmid pLR2 into the ~6.78 kb
BclI fragment of plasmid pEL7 results in illustrative
plasmids pNM702A and pNM702B; ligation of the ~3.4 kb
BamHI fragment of plasmid pLRl or plasmid pLR4 results
in illu~trative plasmids pNM704A and pNM704B; and
ligation of both of the fragments results in illustra-
tive plasmids pNM705A and pNl~705B. Similarly, ligation
of the ~.8 kb BclI fragment of plasmid pLR2 into the
~6.78 kb BclI fragment of plasmid pEL7 results in
10 illustrative plasmids pNM703A and pNM703B; ligation of
both the ~.8 kb BclI and ~3.4 kb BamHI fragments re-
sults in illustrative plasmids pN-~706A and pNM706B;
and ligation of the ~2.8 kb SalI fragment provided with
an appropriate linker, results in illustrative plasmids
15 pNM707A and pNM707B.
Various plasmid pEL7 restriction fragments
can be used for ligation of the antibiotic resistance-
conferring DNA segments provided that the origin of
replication contained in the ~6.78 kb BclI restriction
~o fragment is present. Such plasmid p~L7 restriction
fragments include, but are not limited to, the ~9.1 kb
X I-SacI, ~lO.9 kb SacI, ~4.75 kb XhoI-BclI and ~lO.9_
kb BclI fragments. In addition, a particular antibiotic
resistance-conferring DNA segment is not limited to a
25 single position but can be ligated or inserted into
varying sites of plasmid pE~7 provided that the origin
of replication or other critical plasmid controlled
physiological functions are not disrupted. Those
skilled in the art understand or can readily determine
30 which sites are advantageous for the ligation or inser-
tion o a particular DNA segment.
X~5910 -8-
Although the thiostrepton, neomycin and
erythromycin antibiotic resistance-conferring DNA
segments are respectively exemplified by the ~1.6 kb
BamHI or ~.8 kb BclI fragment of plasmid pLR2, ~3.4 kb
BamHI fragment of plasmid pLR1 and ~2.8 kb SalI restric-
tion fragment of plasmid pIJ43, those skilled in the
art can construct and use, either individually or in
combination, additional DNA segments that also confer
resistance to th~ aforementioned antibiotics. Addi-
1~ tional thiostrepton resistance-conferring DNA segments
of plasmid pLR2 include, for example, the ~13 kb PstI
restriction fragment. Additional neomycin resistance-
conferring DNA segments of plasmid pLRl include, for
example, the ~3.5 kb PstI restriction fragment and also
15 the larger of the SacI-KpnI subfragments of the ~3.4 kb
B HI restriction fragment. Additional fragments that
confer resistance to erythromycin include, for example,
the ~2.5 kb SalI-Bam~I, ~2~7 kb SalI~ 3.0 kb
HindIII, ~2.8 kb XhoI-BglII, and the ~4.1 kb EcoRI-
20 Bam~I restriction fragments of plasmid pIJ43.
Still other DNA segments that confer resis-
tance to the same or to different antibiotics such as,
for example, chloramphenicol, streptomycin, hygromycin,
viomycin, tylosin and the like can also be constructed
and used by those skilled in the art. In addition,
functional derivatives of these or any of the other
antibiotic resistance-conferring DNA segments herein
described can be constructed by adding, eliminating, or
substituting certain nucleotides in accordance with the
30 genetic code. Those skilled in the art will understand
that ligation of these derivatives, or any other anti-
;2~9
X-5910 -9-
biotic resistance-conferring DMA segment, to plasmid
pEL7 origin of replication-containing fragments results
in functionally independent vectors that are also
within the scope of the present invention.
The restriction fragments of plasmids pEL7
and also the various antibiotic resistance-conferring
DNA segments can be modified to facilitate ligation.
For example, molecular linkers can be provided to
either or both of a particular plasmid pEL7 restriction
10 fragment or a particular antibiotic resistance-confer-
ring DNA segment. Thus, specific sites for subsequent
ligation can be constructed conveniently. In addition,
the origin of replication-containing restriction frag-
ments can also be modified by adding, eliminating, or
lS substituting certain nucleotides to provide a variety
of restriction sites for ligation of DNA. Those
skilled in the art understand nucleotide chemistry and
the genetic code and thus which nucleotides are inter-
changeable and which DNA modifications are desirable
20 for a specific purpose.
The present functionally independent vectors
can also be ligated to a restriction fragment of an E.
c _ plasmid such as, for example, pBR322, pBR324,
pBR325, pBR328 and the like, to produce functionally
25 independent vectors that replicate and are selectable
in both E. coli and Streptomyces. These bifunctional
.
constructions comprise the pEL7 origin o replication,
a DNA segment that confers antibiotic resistance in
Streptomyces, a replicon that is functional in E. coli
30 and also a DNA segment that confers antibiotic resis-
tance in E. coli. Biunctional constructions, exem-
~l2~24~
X-5910 -10
plified herein by plasmids pNM708A and pNM708B, are
particularly advantageous because amplification and
manipulation o~ plasmids can be done faster and more
conveniently in _. coli than in Streptomyces. Thus,
after desired recombinant DNA procedures are accom-
plished within the E. coli host system, the entire
plasmid or the particular Streptomyces DNA can be
removed and re-constructed to plasmid-form (if neces-
sary), and then transformed into a Streptomyces or
10 related host cell.
The functionally independent recombinant DNA
cloning vectors of the present invention are not limited
for use in a singlè species or strain of Streptomyces.
To the contrary, the vectors are broadly applicable and
15 can be transformed into host cells of many Streptomyces
taxa, particularly restrictionless strains of economi-
cally important taxa that produce antibiotics such as
aminoglycoside, macrolide, ~-lactam~ polyether and
glycopeptide antibiotics. Such restrictionless strains
20 are readily selected and isolated fro~ Streptomyces
taxa by conventional procedures well ~nown in the art
~Lomovskaya _ al., 1980, Microbiological Reviews
44:20G). Host cells of restrictionless strains lack
restriction enzymes and there~ore do not cut or degrade
25 plasmid DNA upon transformation. For purposes of the
present application, host cells containing restriction
enzymes that do not cut any of the restriction sites of
the present vectors are also considered restriction-
less.
Preferred host cells of restrictionless
strains of Streptomyces taxa that produce aminoglyco-
2-~
X-5910 -11-
side antibiotics and in which the present functionally
independent vectors are especially useful and can be
transformed, include restrictionless cells of, ~or ex-
ample: _. kana-myceticus (kanamycins), S. chrestomy-
ceticus (aminosidine), S. griseoflavus (antibiotic ~A1267), S. microsporeus (antibiotic SF-767), S, ribo-
-
sidificus (antibiotic SF733), _. flavopersicus ~spec-
tinomycin), _. spectabilis (actinospectacin), S.
rimosus forma paromomycinus (paromomycins, catenulin),
-
10 S. fradiae var. italicus (aminosidine), S. bluensis
var. bluensis (bluensomycin), S. catenulae (catenulin),
_. olivoreticuli var. cellulophilus (destomycin A), S.
tenebrarius (tobramycin, apramycin), S. lavendulae
(neomycin), S. albogxiseolus (neomycins), S. albus var.
15 metamycinus (metamycin), S. hygroscopicus var. saga-
miensis (spectinomycin), S. bikiniensis (streptomycin),
S. griseus (streptomycin), S. erythrochromogenes var.
narutoensis (streptomycin), S. pooLensis (strepto-
mycin), _. galbus (streptomycin), S. rameus (strepto-
20 mycin), S. olivaceus (streptomycin), S. mashuensis(streptomycin), S. hygroscopicus var. limoneus (valida-
mycins), S. rimofaciens (destomycins), S.
forma glebosus (glebomycin), _. fradiae (hybrimycins
neomycins), S. eurocidicus (antibiotic A16316-C), S.
2 aquacanus (N-meihyl hygromycin B), S. crystallinus
(hygromycin A), _. noboritoensis (hygromycin), S~_
hygroscopicus (hygromycins), S. atrofaciens (hygro-
mycin), _. kasugaspinus (kasugamycins), S. kasugaensis
(kasugamycins), S. netropsis (antibiotic LL-AM31), S.
30 lividus (lividomycins), S. hofuensis (seldomycin com-
plex), and _. canus (ribosyl paromamine).
62~3
X-5910 -12-
Preferred host cells of restrictionless
strains of Streptomyces taxa that produce macrollde
antibiotics and in which the present functionally
independent vectors are especially useful and can be
transformed, include restrictionless cells of, for
example: S. caelestis (antibiotic M188), . platensis
(platenomycin), _. rochei var. vo7ubilis (antibiotic
T2636), _. venezuelae (methymycins), S. griseofuscus
(bundlin), S. narbonensis (josamycin, narbomycin), S.
10 fungicidicus (antibiotic NA-181), S. griseofaciens
(antibiotic PA133A, B), S. roseocitreus (albocycline),
S. bruneogriseus (albocycline), S. roseochromogenes
(albocycline), S. cinerochromogenes (cineromycin B), S.
albus (albomycetin), S. felleus (argomycin, picromycin),
15 _. rochei (lankacidin, borrelidin), S. violaceoniger
(lankacidin), S. griseus (borrelidin), S. maizeus
.
(ingramycin), S. albus var. coilmyceticus (coleimycin),
S. mycarofaciens (acetyl-leukomycin, espinomycin), S.
hygroscopicus (turimycin, relomycin, maridomycin,
20 tylosin, carbomycin), S. grlseospiralis (relomycin), _.
lavendulae (aldgamycin), S. rimosus (neutramycin), S.
deltae (deltamycins), S. fungicidicus var. espino-
myceticus (espinomycins), S. furdicidicus (mydeca-
mycin), S. ambofaciens (foromacidin D), S. eurocidicus
25 (methymycin), S. griseolus (griseomycin), S. flavo-
chromogenes (amaromycin, shincomycins), S. fimbriatus
(amaromycin), S. fasciculus (amaromycin), S. erythreus
(erythromycins), S. antibioticus (oleandomycin), S.
olivochromogenes (oleandomycin), S. spinichromogenes
_
30 var. suragaoensis (kujimycins), S. kitasatoensis
(leucomycin), _. narbonensis var. josamyceticus (leuco-
2~
X-5910 -13-
mycin A3, josamycin), S. albogriseolus (mikonomycin),
_. bikiniensis (chalcomycin), S. cirratus (cirramycin),
S. djakartensis (niddamycin), S. eury-thermus (angola-
,. _ _
mycln), _. fradiae (tylosin, lactenocin, macrocin), S.
goshikiensis (bandamycin), S. griseoflavus (acumycin),
_. halstedii (carbomycin), S. tendae (carbomycin), S._
macrosporeus (carbomycin), S. thermotolerans (carbo-
mycin), and _. albireticuli (carbomycin).
Preferred host cells of restrictionless
10 strains of Streptomyces taxa that produce ~-lactam
-
antibiotics and in which the present functionally in-
depe.ndent vectors are especially useful and can be
transformed, include restrictionless cells of, for
example: _. lipmanii (A16384, MM45S0, MM13902), S .
15 clavuligerus (A16886B, clavulanic acid), S. lactam-
durans (cephamycin C), S. griseus (cephamycin A, B), S.
hygroscopicus (deacetoxycephalosporin C), 5. wadaya-
mensis (WS-3442-D), S. chartreusis (SF 1623), S.
heteromorphus and S. panayensis (C2081X); S. cinna-
20 monensis, S. fimbriatus, S. halstedii, S. rochei and
_. viridochromogenes (cephamycins A, B); S. cattleya
(thienamycin); and S. olivaceus, S. flavovirens, S.
flavus, S. fulvoviridis, 5. argenteolus, and S. sioya-
ensis (M~l 4550 and MM 13902).
Preferred host cells of restrictionless
strains of Streptomyces taxa that produce polyether
antibiotics and in which the present functionally in-
dependent vectors are especially useful and can be
transformed, include restrictionless cells of, for
30 example: S. albus (A204, A28695A and B, salinomycin),
. hygroscopicus (A218, emericld, DE3936), A120A,
X-5910 -14-
A28695A and B, etheromycin, dianemycin), S. griseus
(grisorixin), S. conglobatus (ionomycin), S. eurocidi-
cus var. asterocidicus (laidlomycin), _. lasaliensis
(lasalocid), S. ribosidificus (lonomycin), S. cacaoi
var~ asoensis (lysocellin), S. cinnamonensis (monen-
sin), S. aureofaciens (narasin), S. gallinarius (RP
30504), S. longwoodensis (lysocellin), S. flaveolus
(CP38936), _. mutabilis (S-11743a), and 5. violaceoni-
ger (nigericin).
Preferred host cells of restrictionless
strains of Streptomyces taxa that produce glycopeptide
antibiotics and in which the present functionally in-
dependent vectors are especially useful and can be
transformed, include restrictionless cells of, for
15 example: _. orientalis and S. haranomachiensis
(vancomycin); S. candidus (A-35512, avoparcin), and S.
eburosporeus (LL-AM 374).
-
Preferred host cells of other Streptomycesrestrictionless strains in which the present function-
20 ally independent vectors are especially useful and canbe transformed, include restrictionless cells of, for
example: S. lividans 1326 (Bibb, M. J. et al., 1977,
J. of Molecular and General Genetics 154:155, Schottel,
J. L. et al., 1981, J. of Bacteriology 146 (1):360, and
25 Bibb, M. J. et al., 1981, J. of Molecular and General
Genetics 148:230), S. coelicolor, S. _anuloruber, S.
roseosporus, S. lividans, S. tenebrarius, S. espinosus,
S. acrimycins, S. glaucescens, S. parvilin, S. pristina-
espiralis, S. violaceoruber, S. vinaceus and S. azureus.
_
In addition to the representative Strepto-
myces host cells described above, the present function-
ally independent vectors are also useful and can be
;z~
X-5910 -15-
transformed into cells of restrictionless strains of
other taxa such as, for example: ~acillus, S-taphylo-
coccus and related Actinomycetes, including Strepto-
sporangium, Actinoplanes, Nocardia, and Micromonospora.
Thus, the vectors of the present invention have wide
application and are useful and can be transformed into
host cells of a variety of organisms.
While all the embodiments of the present
invention are useful, some of the present recombinant
10 DNA cloning vectors and transformants are preferred.
Accordingly, preferred vectors are plasmids pNM702A,
pNM703A, pNM704A, pNM705A, pNM706A, pNM707A and
pNM708A; and preferred transformants are Streptomyces
ambofaciens/pNM702A, S. ambofaciens/pN~1703A, S. lividans
15 1325/pNM703A, _. ambofaciens/pNM704A, S. ambofaciens/-
pNM705A, S. ambofaciens/pNM706A, S. ambofaciens/pNM707A,
S. ambofaciens/pNM70~A and E. coli K12 HB101/pNM708~.
Moreover, of this preferred group, plasmids pNM702A,
pNM703A, pNM705A, and pNM707A and transformants S.
20 ambofaciens/pNl~702A, S. ambofaciens/pNM703A, S. lividans
1326/pNM703A, S. ambofaciens/pNM705~ and S ambofaciens/-
pNM707A are most preferred.
The functionally independent recombinant DNA
cloning vectors and transformants of the present inven-
25 tion have broad utility and help fill the need forsuitable cloning vehicles for use in Streptomyces and
related organisms. ~loreover, the ability of the pres-
ent vectors to confer resistance to antibiotics that
are toxic to non-transformed host cells, also provides
30 a functional means for selecting transformants. This
is important because of the practical necessity for
:~2~;Z~
X~5910 -16-
determining and selecting the particular cells that
have acquired vector DNA. Additional DNA segments,
that lack functional tests for their presence, can also
be inserted onto the present vectors and then trans-
formants containing the non-selectable DNA can be
isolated by appropriate antibiotic selection. Such
non-selectable DNA segments can be inserted at any
site, except within regions necessary for plasmid
function and replication, and include, but are not
10 limited to, genes that specify antibiotic modification
enz~mes and regulatory genes of all types.
More particularly, a non-selectable DNA seg-
ment that comprises a gene is inserted on a plasmid
such as for example, illustrative plasmid pN~705A, at
15 the central SalI or sub-terminal PvuII restriction site
of the ~1.6 kb BamHI resistance-conferring fragment.
Such an insertion inactivates the thiostrepton resis-
tance gene and thus allows for the easy identification
of transformants containing the recombinant plasmid.
This is done by first selecting for neomycin resistance
and, secondarily, identifying those neomycin resistant
transformants that are not resistant to thiostrepton.
In a similar manner, insertion of a DNA segment of
interest at, for example, the internal BamHI restric-
25 tion site of the ~3.4 kb BamHI resistance-conferring
fragment inactivates the neomycin resistance gene.
Thus, transformants carrying this recombinant plasmid
also are identified easily by first selecting for
thiostrepton resistance and, secondarily, identifying
3G those thiostrepton resistant transformants that are not
resistant to neomycin. Similar selection involving the
X-5910 -17-
insertional inactivation of the erythromycin yene can
also be done. Therefore, the ability to select for
antibiotic resistance in Streptomyces and related cells
allows for -the efficient isolation of the extremely
rare cells that contain the particular non-selectable
DNA of interest.
The functional test for antibiotic resis-
tance, as described herein above, is also used to
locate DNA segments that act as control elements and
10 direct expression of an individual antibiotic resis-
tance gene. Such seqments, including but not limited
to, promoters, attenuators, repressors, inducers,
ribosomal binding sites, and the like, are used to
control the expression of other genes in cells of
15 Streptomvces and related organisms.
-
The thiostrepton, neomycin and erythromycinresistance-conferring functionally independent vectors
of the present invention are also useul for insuring
that linked DNA segments are stably maintained in host
20 cells over many generations. These genes or DNA frag-
ments, covalently linked to the thiostrepton, erythro-
mycin or neomycin resistance-conferring fragment and
propagated either in Streptomyces or in the cells of
related organisms, are maintained by exposing the
25 transformants to levels of thiostrepton, erythromycin
or neomycin that are toxic to non-transformed cells.
Therefore, transformants that lose the vector, and
consequently any covalently linked DNA, cannot grow and
are eliminated ~rom the culture. Thus, the vectors of
30 the present invention can stabilize and maintain any
DNA sequence of interest.
~21 EiZ~
X-5910 -18-
The functionally independent cloning vectors
and transformants of the present invention provide for
the cloning of genes to improve yields of vaxious
products that are curren-tly produced in _treptomyces
and related cells. Examples of such products include,
but are not limited to, Streptomycin, Tylosin, Cephalo-
sporins, Actaplanin, Narasin, Monensin, Apramycin,
Tobramycin, Erythromycin, and the like. The present
invention also provides selectable vectors that are
10 useful for cloning, characterizing and reconstructing
DNA sequences that code for commercially important
proteins such as, for example, human insulin, human
proinsulin, glucagon, interferon, human growth hormone,
bovine growth hormone and the like; for enzymatic
15 functions in metabolic pathways leading to commercially
important processes and compounds; or for control
elements that improve gene expression. These desired
DNA sequences include, but are not limited to, DNA that
codes for enzymes that catalyze synthesis of deriva-
20 tized antibiotics such as, for example, Streptomycin,Cephalosporin, Tylosin, Actaplanin, Narasin, Monensin,
Apramycin, Tobramycin and Erythromycin derivatives, or
for enzymes that mediate and increase bioproduction of
antibiotics or other products. The capability for in-
25 serting and stabilizing such DNA segments thus allowsfor increasing the yield and availability of antibiot-
ics that are produced by Streptomyces and related
organisms.
Streptomyces ambofaciens/pEL7~ as a source of
30 plasmid pEL7, can be cultured in a number of ways using
any of several different media. Carbohydrate sources
~Z~ 9
X-5910 -19-
which are preferred in a culture medium include, for
example, molasses, glucose, dextrin, and glycerol, and
nitrogen sources include, for example, soy flour, amino
acid mixtures, and peptones. Nutrient inorganic sa]ts
are also incorporated and include the customary salts
capable of yielding sodium, potassium, ammonia, cal-
cium, phosphate, chloride, sulfate, and like ions. As
is necessary for the growth and development of other
microorganisms, essential trace elements are also
10 added. Such trace elements are commonly supplied as
impurities incidental to the addition of other constit-
uents of the medium.
Streptomyces ambofaciens/pEL7 is grown under
aerobic culture conditions over a relatively wide pH
15 range of about 5 to 9 at temperatures ranging from
about 15 to 40 ac . For production of plasmid pEL7 at
the highest copy number, however, it is desirable to
start with a culture medium at a pH of about 6.5 and
maintain a culture temperature of about 30C. Cultur-
20 ing Streptomyces ambofaciens/pEL7, und~r the aforemen-
_
tioned conditions, results in a reservoir of cells fromwhich plasmid pEL7 is isolated conveniently.
The following examples further illustrate and
detail the invention disclosed herein. Both an expla-
25 nation of and the actual procedures for constructingthe invention are described where appropriate.
X-5910 -20-
Example 1
Isolation of Plasmid pEL7
A. Culture of Streptomyces ambofaciens/pEL7
. .
A vegetative inoculum of Streptomyces ambo-
faciens/pEL7 (~RRL 12523) was conventionally prepared
_ .
by growing the strain under submerged aerobic condi-
tions in 50 ml. of sterilized vegetative medium with
the following preferred composition.
Ingredient Amount
.
Glucose 20 g./l.
*
"Nutrisoy" flour 15 g./l.
Corn steep liquor 10 g./l.
15 CaCO3 2 g./l.
Water (tap) 1.1 1.
*'INutrisoy'' flour is obtained from Archer Daniels
Midland Company, 4666 Faries Parkway, Decatur,
Illinois 62526.
Corn steep liquor is obtained from CPC Inter-
national, Corn Products, P.O. Box 3000, Englewood,
N.J. 07632.
The vegetative inoculum was incubated for 48
hours a~ a temperature of 30C. and a pH of 6.5. After
incubation, about 1.0 ml. of the inoculum was trans-
ferred to 50 ml. of sterilized cell production m~dium
with the following preferred composition.
Trademark
~ .. j7~ '
X-5910 -21-
Ingredient Amount
"Trypticase" s-oy ~roth 30 y./l.
Glucose 10 g./l.
Glycine 1 g./1.
Deionized water 1 g./1.
*''Trypticase'l2 soy broth is obtained from Difco Lab-
oratories, Detroit, Michigan.
The inoculated cell production medi~m was
10 incubated for about 20 hours at 30C. The pH was not
adjusted. After incubation, the Streptomyces ambo-
faciens/pEL7 cells were ready for harvest and subse-
. .
quent isolation of plasmid DNA.
B. Plasmid Isolation
About 10 g. (wet wgt) of Streptomyces ambo-
faciens/pEL7 cells were harvested by centrifugation (10
minutes, 5~C., 10,000 rpm). The cells were homogenized
using a tissue grinder, washed in TES buffer (0.05M
20 tris(hydroxymethyl)aminomethane [tri~], 0.005M EDTA,
and 0.05M NaCl, pH 8.0), and then suspended in TES
buffer containing 25~ sucrose. After the addition of
about 120 mg. of lysozyme in 20 ml. of T~S-25% sucrose
buffer, the suspension was incubated at 35~37C. for
25 about 20 minutes and, upon addition of 40 ml. of 0.25M
EDTA, pH 8.0, the suspension was again incubated at
35C. for 10 minutes. Following this, about 40 ml. of
5% SDS (sodium dodecyl sulfate) in TE buffer (O.OlM
tris, G.OOlM EDTA, pH 8.0) was added and then, after
the resultant mixture was again incubated at 35-37~C.
for 20 minutes, about 50 ml. of SM NaCl in deionized
water was added. The mixture was stirred, placed on an
Trademark
X-5910 -22-
ice bath for about 4 hours and then centrifuged (30
minutes, 4C., 10,000 rpm). About .313 volumes of 42%
polyeth~lene glycol in deionized water were added to
the NaCl supernatant and the resulting mixture was
cooled at 4C. for about 18 hours. The DNA precipitate
was collected by centrifugation (5 minutes, 4C., 3000
rpm) and was then dissolved in TES buffer at pH 8Ø
Centrifugation (40 hours, 15C., 35,000 rpm) using
cesium chloride and ethidium bromide gradients sepa-
10 rated the DNA into two well defined bands with thelower band constituting the desired plasmid pEL7.
Following conventional procedures, the plasmid band was
removed, washed twice with isoamyl alcohol, dialyzed
over TE buffer at pH 8.0 and precipitated with ethanol.
15 The thus isolated plasmid pEL7 DNA was dissolved in
.4 ml. of TE buffer at pH 8.0, and was then rozen
at -20C. for storage.
Example 2
Construction of Plasmid pLR2
A. HindIII Digestion of Plasmid pIJ6
About 20 ~1. t20 ~g.) of plasmid pIJ6 DNA,
disclosed in Thompson et al., 1980, Nature 286:525,
25 5 ~1. BSA (Bovine serum albumin, 1 mg./ml.), 19 ~1.
water, 1 ~1. of HindIII (containing 3 new England Bio
Lab Units) restriction enzyme and 5 ~1. reaction mix
were incubated at 37C. for 2 hours. The reaction was
terminated b~ the addition of about 50 ~1. of 4M a~umoni-
30 um acetate and 200 ~1. of 95% ethanol. The resultantDNA precipitate was washed twice in 70% ethanol, dried
in vacuo, suspended in 20 ~1. of TE buffer, and frozen
-
at -20C. for storage.
Z4g
X-5910 -23-
Restriction enzymes can be obtained from the
following sources:
New England Bio Labs., Inc.
32 Tozer Rd.
Beverly, Massachusetts 01915
Boehringer-Mannheim Biochemicals
7941 Castleway Dr~
Indianapolis, Indiana 46250
Reaction mix for HindIII restriction enzyme was
prepared with the following composition.
600 mM NaCl
100 mM Tris-HCl, pH 7.9
70 ~M MgC12
10 mM Dithlothreitol
B. ~lindIII Digestion of Plasmid pBR322
About 8 ~1. (4 ~g.) of plasmid pBR322 DNA,
5 ~1. reaction mix, 5 ~1~ BSA (1 mg./ml.), 31 ~1.
water and 1 ~1. of HindIII restriction enzyme were
incubated at 37C. for 2 hours. After the reaction was
2~ terminated by incubating at 60C. for 10 minutes, about
50 ~1. of ammonium acetate and 200 ~1. of 95% ethanol
were added. The resultant DNA precipitate was washed
twice in 70% ethanol, dried in vacuo, and suspended in
45 ~1. of water.
25 C. Ligation of HindIII Digested Plasmids pIJ6 and
.
pBR322
About 20 ~1. of HindIII treated plasmid pIJ6
(from Example 2A), 20 ~1. of HindIII treated plasmid
p~R322 (from Example 2B), 5 ~1. BSA (1 mg /ml.), 1 ~1.
of T4 DNA ligase , and 5 ~1. ligation mix were
incubated at 16C. for 4 hours. The reaction was
~Z~62~ ,
X-5910 -24-
terminate~ by the addition of about 50 ~1. 4M ammonium
acetate and 200 ~1. of 95~ ethanol. The resultant DNA
precipitate was washed twice in 70~ ethanol, dried ln
vacuo, and suspended in TE buffer. The suspended DNA
S constituted the desired plasmid pLR2.
*
T4 DNA ligase can be o~tained from the following
source:
New England Bio Labs., Inc.
1032 Tozer Rd.
Beverly, Massachusetts, 01915
Ligation mix was prepared with the following com-
position:
500 mM Tris - ~Cl, pH 7.8
200 mM Dithiothreitol
100 mM MgC12
15 10 mM ATP
Example 3
Constr~ction of E. coli K12 HB101/pLR2
About 10 ml. of frozen competent E. coli K12
20 HB101 cells (Bolivar et al., 1977, Gene 2:75-93) were
pelleted by centrifugation and then suspended in about
10 ml. of O.OlM sodium chloride. Next, the cells were
pelleted again, resuspended in about 10 ml. of .03M
calcium chloride solution, incubated on ice or 20 min-
25 utes, pelleted a third time and finally resuspended in1.25 ml. of .03M calcium chloride solution. The
resultant cell suspension was competent for subsequent
transformation.
Plasmid pLR2 in TE buffer (prepared in Exam-
30 ple 2C) was ethanol precipitated, suspended in 150 ~1.
of 30mM calcium chloride solution and gently mixed in a
31 Zt~9
X-5910 -25-
test tube with about 200 ~1. of competent E. coli K12
HB101 cells. The resultant mixture was incubated on
ice for about 45 minutes and then at 42C. for about 1
minute. Next, about 3 ml. of L-broth (Bertani, 1951,
J. Bacteriology 62:293) containing 50 ~g./ml. of ampi-
cillin was added. The mixture was incubated with shak-
ing at 37C. for 1 hour and then plated on L-agar
(Millex, 1972, Experiments in Molecular C-enetics, Cold
Spring Harbor Labs, Cold Spring Harbor, New York) con-
10 taining ampicillin. Surviving colonies were selectedand tested for the expected phenotype (AmpR, TetS,) and
constituted the desired ~. coli K12 HB101/pLR2 trans-
formants.
Example 4
Construction of Plasmid pLRl
Plasmid pLRl was prepared in substantial
accordance with the teaching of Example 2A-C except
that plasmid pIJ2, disclosed in Thompson et al., 1980,
20 Nature 286:525, was used in place of plasmid pIJ6. The
desired plasmid pLRl was suspended in TE buf~er.
Example 5
Construction of E. coli K12 HB101/pLRl
The desired construction was carried out in
substantial accordance with the teaching of Example 3
except that plasmid pLRl, rather than plasmid pLR2, was
used for transformation. Surviving colonies were
selected and tested for the expected phenotype (AmpR,
30 Tet ,) and constituted the desired E. coli X12 HBlQl/
pLRl transformants.
-
g
X-5910 -26-
xample 6
Construction of Plasmid pLR4
A. Partial B HI Digestion of Plasmid pLRl
About 10 ~1. (10 ~g.) of plasmid pLR1, S ~1. BSA
(1 mg./ml.), 29 ~1. water, 1 ~1. of BamHI (diluted 1:4
with water) restriction enzyme, and 5 ~1. reaction
mix* were incubated at 37C. for 15 minutes. The reac-
tion was terminated by the addition of about 50 ~1. of
10 4M ammonium acetate and 200 ~1. of 95% ethanol. The
resultant DNA precipitate was washed twice in 70
ethanol, dried ln vacuo, and suspended in 20 ~1.
water.
Reaction mix for BamHI restriction enz~me was pre-
par~d with the following composition.
1.5M NaCl H
6~mM Tris~HCl, p 7.9
60m~ MgC12
B. BamHI Digestion of Plasmid pBR322
The desired digestion was carried out in sub-
stantial accordance with the teaching of Example 2B
except that BamHI restriction enzyme was used in place
of HindIII restriction enzyme. The digested plasmid
25 pBR322 was suspended in 29 ~1. of water.
C. Ligation of Partial BamHI Digested Plasmid pLRl
.
and BamHI Digested Plasmid pBR322
-
The desired ligation was carried out in sub-
30 stantial accordance with the teaching of Example 2C.
The resultant ligated DNA was suspended in TE buffer
and constituted the desired plasmid pLR4.
~2~62~g
X-5910 -27-
Example 7
Construction of E. coli K12 HB101/pLR4
The desired construction was carried out in
substantial accordance with the teaching of Example 3
except that plasmid pLR4, rather than plasmid pLR2, was
used for transformation. Surviving colonies were se--
lected and tested for the expected phenotype (AmpR,
TetS) and constituted the desired E. coli K12 HB101/
10 pLR4 transformants.
Example 8
Construction of Plasmids pNM702A and pNM702B
A. BamHI Digestion of Plasmid pLR2 and Isolation of
.
15 the ~1.6kb Thiostrepton Resistance-Conferring
Fragment
About 25 ~g. of plasmid pLR~ DNA, 10 ~1.
reaction mix, 5 ~1. .lM dithiothreitol, 10 ~1. BSA
(1 mg./ml.), 45 ~1. water, and 5 ~1. (4 units/~l.) of
20 BamHI restriction enæyme were incubated at 37C. for 2
hours. After adding an equal volume of 4M ammonium
acetate and 2 volumes of 95% ethanol, the mixture was
cooled at -20C. for about 18 hours to precipitate the
DNA. The DNA precipitate was collected by centrifuga-
25 tion and then suspended in about 50 ~1. of TE buffer.The desired ~1.6 kb BamHI restriction fragment was iso-
lated conventionally from the DNA suspension by agarose
gel electrophoresis in substantial accordance with the
teaching of Wieslander, L., 1979, Analytical Biochem-
30 istry 98:305. Following isolation, the fragment wasresuspended in about 20 ~1. of TE buffer for subsequent
ligation.
,~
~2~
X-5910 -28-
B. BclI Digestion of Plasmid pEL7
The desired digestion was carried out at
~50C. in substantial accordance with the teaching of
Example 8A except that plasmid pEL7 and BclI restric-
tion enzyme and reaction mix*, rather than plasmid pLR2
and BamHI restriction enzyme and reaction mix, were
used. In addition, the DNA digest was not electro-
phoresed but was suspended dir~ctly in 20 ~1. of TE
buffer for subsequent~ligation.
*
Reaction mix for BclI reaction mix was prepared with
the following composition~
12 mM NaCl
12 mM Tris-HCl, pH7.4
12 mM MgC12
.5 mM Dithiothreitol
C. Ligation
A mixture of about 20 ~g. of BclI restricted
20 plasmid pEL7 DNA, 10 ~g. of the ~1.6 kb BamHI restric-
tion fragment of plasmid pLR2, 5 ~1. BSA (1 mg./ml.),
10 ~l. ligation mix, 45 ~1. water and 3.5 ~1. T4 DNA
ligase were incubated at about 16C. for about 18
hours. After adding .1 volume of 3M ammonium acetate
25 and 2 volumes of cold ethanol, the mixture was cooled
to -20C. for about 18 hours to precipi-tate the DNA.
The DNA precipitate was collected by centrifugation,
washed with 70~ ethanol, collected again and then
suspended in 50 ~1. of medium P (Hopwood and Wright,
30 1978, J. Molecular and General Genetics 162:307) for
subsequent transformation.
X-5910 ~29
Recombinant plasmids of two orientations
result depending upon the orientation of the inserted
~1.6 kb BamHI thiostrepton resistance-conferring ~rag-
ment. Plasmid pNM702A designates the resultant recom-
binant plasmid in which the sub-terminal SalI restric-
tion site of the resistance-conferring fragment is
inserted closest to the flanking SacI site of plasmid
pEL7. Plasmid pNM702B designates the recombinant
plasmid with the reverse orientation. Thus, the final
10 DNA suspension contains plasmids pNM702A and pNM702B.
A restriction site map of each of plasmids pNM702A
and pNM702B is presented in Figure 3 of the accompany-
ing drawings.
Example 9
Construction of Streptomyces ambofaciens/pEL702A
-
and S. ambofaciens/pEL702B
Using about ~ ~g. DNA from Example 8C and
20 1 x 108 protoplasts of Streptomyces ambofaciens, a
strain deposited and made paxt of the stock culture
collection of the Northern Regional Research Labora-
tory r Peoria, Illinois, from which it is available to
the public under the accession number NRRL 2420, the
desired constructions were made in substantial accord-
ance with the teaching of In~ernational Publication ~of
International Patent Application No. PCT/GB 79/00095)
No. WO79/01169, Exa~ple 2. The desired transformants
were selected fox thiostrepton resistance by plating on
30 Bennett's Modified Medium containing about 50 ug./ml.
of antibiotic thiostrepton. The resultant Streptomyces
ambofaciens/pNM702A and _. ambofaciens/pNM702B thio-
4~
X-5910 -30-
strepton resistant colonies were isolated, cultured,
and then conventionally identified by restriction
enzyme and agarose yel electrophoretic analysis of the
constitutive plasmids (Wieslander, 1979). The trans-
formant cultures were used for subsequent productionand isolation of their respective plasmids.
*
Bennett's medium (Agar), disclosed in Waksman,
1961, The Actinomycetes, Volume II, The Williams
and Wilkins Company, Baltimore, Maryland, was
modified by adding CoC12 6H O (.01 g./L.) and by
replacing glucose with dex~rin.
- Example 10
Construction of Plasmids pNM704A and pNM704B
_
15 A. BàmHI Digestion of Plasmid pLRl and Isolation of
-
the ~3.4 kb Neomycin Resistance-Conferring Fragment
About 50 ~g. of plasmid pLRl DNA, 20 ~1.
reaction mix~, 10 ~1. O.lM dithiothreitol, 20 ~1. BSA
20 (1 mg./ml.), 45 ~1. water and 5 ~1. (4 units/ul.) of
PstI restriction en~yme* were incubated at 37C. for 2
hours. After adding an equal volume of 4M ammonium
acetate and 2 volumes of 95~ ethanol, the mixture was
cooled at -20C. or about 18 hours to precipitate the
DNA. The DNA precipitate was collected by centrifuga-
tion and then suspended in about 50 ~1. of TE bufer.
The desired ~3.4 kb BamHI restriction fragment was iso-
lated conventionally from the DNA suspension by agarose
gel electrophoresis (~ieslander, 1979). Following
3 isolation, the fragment was resuspended in about
20 ~1. of TE buffer for subsequent ligation.
2~
X-5910 -31-
B. L_ ation
The desired ligation is carried out by react-
ing about 20 ~g. of BclI restricted plasmid pEL7 DNA
(prepared in Example 8B) and about 19 ~y. of the ~3~4
kb BamHI restriction fragment of plasmid pLR1 in sub-
stantial accordance with the teaching of Example 8C.
Recombinant plasmids of two orientations
result depending upon the orientation of the insex-ted
~3.4 kb BamHI neomycin resistance-conferring fragment.
10 Plasmid pNM704A designates the recombinant plasmid in
which the sub-terminal PstI restriction site of the
resistance-conferring fragment is inserted closest to
the flanking SacI site of plasmid pEL7. Plasmid pNM704B
designates the recombinant plasmid with the reverse
15 orientation. Thus, the final DNA suspension contains
plasmids pNM704A and pNM704B. A restriction site map
of each of plasmids pNM704A and pNM704B is presented in
Figure 3 of the accompanying drawings.
Example 11
Construction of Streptomyces ambofaciens/pNM704A
and S. ambofaciens/pNM704B
Using about 2 ~g. DN~ from Example lOC and
25 1 x 10 protoplasts of Streptomyces ambofaciens, tNRRL
No. 2420), the desired constructions are made in
substantial accordance with the teaching of Interna-
tional Publication (of International Patent Application
No. PCT/GB 79/00095) No. W079/01169, ~xample 2. The
30 desired transformants are selected for neomycin resis-
tance by plating on Bennett's Modified Medium contain-
X-5910 -32-
iny about l ~g./ml. of antibiotic neomycin*. The
resultant Streptomyces ambofaciens/pNM704A and S.
ambofaciens/pNM704B neomycin resistant colonies are
isolated, cultured and then conventionally identified
by restriction enzyme and agarose gel electrophoretic
analysis of the constitutive plasmids (Weislander,
1979). The transformant cultures are used for subse-
quent production and isolation of their respective
plasmids.
-
Antibiotic neomycin can be obtained from Sigma,
St. Louis, Missouri.
Example 12
lS Construction of Plasmids pNM705~ and pNM705B
A. Isolation of Plasmlds pNM702A
The desired plasmid is isolated from Strepto-
myces ambofaciens/pNM702A (prepared in Example 9 and
_
20 cultured according to the teaching of Example lA) in
substantial accordance with the isolation procedure of
Example lB. The thus isolated plasmid pNM702A DNA is
suspended in TE buffer at pH8.0 for subsequent restric-
tion enzyme digestion.
25 B. Partial BclI Digestion of Plasmid pNM702A
The desired digestion is carried out in
substantial accordance with the teaching of Example 6A
except tha-t plasmid pNM702A DNA and BclI restriction
enzyme and reaction mix, rather than plasmid pLR~ and
BamHI restriction enzyme and reaction mix, are used.
2~9
X-5910 ~33~
The thus digested DNA is suspended in 20 ~1. of TE
buffer for subsequent ligation with the ~3.4 kb BamHI
restriction fragment of plasmid pLRl.
C. Ligation
The desired ligation is carried out by react-
ing about 20 ~g. of the BclI restricted plasmid pNM702A
DNA and about lO ~g. of the ~3.4 kb BamHI restriction
fragment (prepared in Example lOA) in substantial ac-
10 cordance with the teaching of Example lOC.
Recombinant plasmids of two orientations re-
sult depending upon the orientation of the inserted
~3.4 kb BamHI neomycin resistance-conferring fragment.
Plasmid pNM705A designates the recombinant plasmid in
15 which the sub-terminal PstI site of the resistance-
conferring fragment is inserted closest to the flank-
ing SacI site of plasmid pNM702A. Plasmid pNM705B
designates the recombinant plasmid with the reverse
orientation. In addition, the insertional isomers of
20 plasmids pNM705A and pNM705B are also produced since
plasmid pNM702A has two BclI restriction sites for the
insertion of the neomycin resistance-conferring frag-
ment. A restriction site map of each of plasmids
pNM705A and pNM705B is presented in Figure 4 o the
25 accompanying drawings.
Example_13
Construction of Streptomyces ambofaciens/pNM705A
and S. ambofaciens/pNM705B
Using about 2 ~g. DNA from Example 12C and
1 x 108 protoplasts of Streptomyces ambofaciens, (NRRL
z~
X 5910 -34~
No. 2420), the desired constructions are made in sub-
stantlal accordance with the teaching of International
Publication (of International Patent Application No.
PCT/GB 79/00095) No. W079/01169, Example 2. The de-
sired transformants are selectea for thiostrepton andneomycin resistance by plating on Bennett's Modified
Medium containing about 50 ~g./ml. of antibiotic thio-
strepton and 1 ~g./ml. of antibiotic neomycin. The re-
sultant Streptomyces ambofaciens/pNM705A and S. ambo-
10 faciens/pNM705B thiostrepton and neomycin resistantcolonies are conventiona]ly isolated, cultured and then
identified by restriction enzyme and agarose gel elec-
trophoretic analysis of the constitutive plasmids
(Wieslander, 1979). The transformant cultures are
15 used for subse~uent production and isolation of their
respective plasmids.
Example 14
Construction of Plasmids pNM703A
_
and pNM703B
A. BclI Digestion of Plasmid pLR2 and Isolation of
. . . _ . . _ _ . _ .
the ~.8 kb Thiostrepton Resistance-Conferring
E'ragmen-t
The desired digestion was carried out in
substantial accordance with the teachin~ of Example 8A
except that BclI restriction enzyme and reaction mix,
rather than BamHI restriction enzyme and reaction mix,
were used. The desired ~.~ kb BclI restriction frag-
30 ment was isola-ted conventionally from the DNA suspen-
sion by agarose gel electrophoresis in substantial
2~
X-5910 -35-
accordance with the teaching of Weislander, 1979.
Following isolation, the fragment was resus-
pended in about 20 ~1. of TE buffer for subsequent
liga~ion.
B. Ligation
About 20 ~g. of BclI restricted plasmid pEL7
DNA (prepared in Example 8B) and lO ~g. of the ~.8 kb
BclI restriction fragment of plasmid pLR2 were ligated
lO in substantial accordance with the teaching of Example
8C.
Recombinant plasmids of two orientations
result depending upon the orientation of the inserted
~.8 kb BclI thiostrepton resistance-conferring frag-
15 ment. Plasmid pNM703A designates the resultant re-
combinant plasmid in which the sub-terminal PvuII re-
striction site of the resistance-conferring fragment is
inserted away from (not closest to) the flanking SacI
site of plasmid pEL7~ Plasmid pNM703B designates the
recombinant plasmid with the reverse orientation.
Thus, the final DNA suspension contains plasmids
pNM703A and pNM703B. A restriction site map of each of
plasmids pNM703A and pNM703B is presented in Figure 4
of the accompan~ing drawings.
Example 15
Construction of Streptomyces ambofaciens/pNM703A
and S. ambofaciens/pNM703B
-
Using DNA prepared in Example 14, the desired
30 transformants were constructed in substantial accoxd-
ance with the teaching of Example 9. The resultant
X-5910 -36-
Streptomyces ambofaciens/pNM703A and S. ambofaciens/-
pNM703B thiostrepton resistant colonies were isolated,
cultured and then conventionally identified by restric-
tion enzyme and agarose gel electrophoretic analysis of
the constitutive plasmids (Weislander, 1979). The
transformant cultures were used for subsequent produc-
tion and isolation of their respective plasmids.
Example 16
Construction of Plasmids pNM706A
and pNM706B
The desired constructions are made in sub-
stantial accordance with the teaching of Example 12A-C
except that plasmid pNM703A ~isolated from Streptomyces
15 ambofaciens/pNM703A of Example 15), rather than plasmid
-
pNM704A, is used.
Recombinant plasmids of two orientations re-
sult depending upon the orientation o~ the inserted
~3.4 kb BamHI neomycin resistance-conferring fragment.
20 Plasmid pNM706A designates the recombinant plasmid in
which the sub-terminal PstI restriction site of the
resistance-conferxing fragment is inserted closest to
the flanking SacI site of plasmid pNM703A. Plasmid
pNM706B designates the recombinant plasmid with the
25 reverse orientation. In addition, the insertional
isomers of plasmids pNM706A and pNM706B are also pro-
duced since plasmid pNB703A has two BclI restriction
sites for the insertion of the neomycin resistance-
conferring fragment. A restriction site map or each of
30 plasmids pNM706A and pNM706B is present~d in Figure 5
of the accompanying drawings.
X-5910 ~37~
Example 17
Construction of Streptomyces ambofaciens/-
pNM706 and S. ambofaciens/pNM706B
Using about 2 ~g. of DNA from Example 16,
the desired constructions are made in substantial
accordance with the teaching of Example 13. The re-
sultant Streptomyces ambofaciens/pNM706A and S. mbo-
faciens/pNM706B thiostrepton and neomycin resistant
lO colonies are conventionally isolated, cultured and
then identified by restriction enzyme and agarose gel
electrophoretic analysis of the constitutive plasmids
(Weislander, 1979). The transformant cultur~s are used
for subsequent production and isolation of their re-
15 spective plasmids.
Example 18
Construction of Plasmids pNM707A and pNM707B
_
A. Culture of E. coli 803/pIJ43 and Isolation or
O
Plasmid pIJ43
The desired cultu-ring of E. coli 803/pIJ43
(ATCC 39156) and the subsequent isolation o~ plasmid
pIJ43 are both carried out in substantial accor~ance
~5 with the teaching of Davis, R. W~ et al , 1980, A
~anual For Genetic Engineering, Advanced Bacterial
Genetics, Cold Spring Harbor Laboratories, Cold Spring
Harbor, New ~ork. The pIJ43 DNA is conventionally
suspended in TE buffer and then cooled to -20C. for
30 storage.
X-~910 -38-
B. Digestion and Isolation o~ ~2 8 kb SalI Fragment
o plasmid pIJ~3
About 20 ~g. of plasmid pIJ43 DNA, 10 ~1.
reaction mix , lO ~1. BSA (l mg./ml.) 39 ~1. water, and
1 ~1. of SalI restriction enzyme (prepared by diluting
in such a manner that 1 ~1. contains about 60 New
England Bio. Lab. units) were incubated at ambient
temperature for about 60 minutes. After adding an
equal volume of 4M ammonium acetate and 2 volumes of
lO 95~ ethanol, the mixture was cooled at -20C. for about
18 hours to precipitate the DNA. The DNA precipitate
was collected by centrifugation. The desired ~2.8 kb
SalI fragments are separated and isolated convention-
all~ by agarose gel electrophoresis (Weislander, 1979).
Reaction mix for SalI restriction enzyme was preparedwith the following composition.
1.5 M NaCl
6~ mM Tris-HCl, pH 7.9
60 mM MgCl
60 mM 2-mercaptoethanol
C. Addition of BclI Linkers~to the ~2.8 kb S
Fragment of Plasmid pIJ43
The addition of BclI linkers is carried out
in substantial accordance with the teaching of Ullrich
_ al., 1977, Science 196:1313. The resultant fragment
is treated with BclI restriction enzyme to produce the
desired 8clI sticky termini. The 32.8 kb BclI fragment
30 is then isolated according to known procedures and
stored for subsequent ligation.
62~
X-5910 -39~
BclI[d(CGGATCCG)I and other linkers are readily
available at:
Collaborative Research Inc.
128 Spring Street
Lexington, Massachusetts 02173
D. Ligation
About 1 ~g. of BclI digested plasmid pEL7
(prepared in Example 8B) and l ~g. of the ~2.8 kb
lO fragment of plasmid pIJ43 (prepared in Example 18B and
C), are ligated in substantial accordance with the
teaching of Example 8C.
Recombinant plasmids of two orientations
result depending upon the orientation of the inserted
15 ~2.8 kb BclI erythromycin resistance-conferring frag-
ment. Plasmid pNM707A designates the recombinant
plasmid in which the sub-terminal Pstl site of the
resistance-conferring fragment is inserted closest to
the flanking SacI site of plasmid pEL7. Plasmid
20 pNL~707B designates the recombinant plasmid with the
reverse orientation. A site map of each of plasmids
pNM707A and pNM707B is presented in Figure 5 of the
accompanying drawings.
Example l9
Construction of Streptomyces ambofaciens/pNM707A and
S. ambofaciens/pNM707B
The desired constructions are made in sub- -
30 stantial accordance with the teaching of Example 9
except that plasmid pNM707A and pNM707B DNA, rather
than DNA from Example 8C, is used. The desired trans~
X-5910 ~40-
formants are selected for erythromycin resistance by
overlaying the regenerating protoplasts with R2 medium
top agar containing sufficient erythromycin to bring
the plate concentration to 50 ~g./ml. The resultant
Streptomvces ambofaciensfpNM707A and S. ambofaciens/-
-
pN~1707B erythromycin resistant colonies are isolated
according to known procedures, cultured and then
conventionally identi~ied by restriction enzyme and
agarose gel electrophoretic analysis of the constitu-
10 tive plasmids (Wieslander, 1979). The transformantcultures are used for subsequent production and iso-
lation of their respective plasmids.
Example 20
Construction of Plasmids
pNM708A and pNM708B
A. Addition of BclI Linkers to BamHI Digested Plasmid
-
pBR322
The addition of BclI linkers to BamHI di-
gested plasmid pBR322 (prepared in Example 6B) is car-
ried out in substantial accordance with the teaching of
Ullrich et al., 1977, Science 196:1313. The resultant
fragment is treated with BclI restriction enzyme to
25 produce the desired BclI stick~ termini. The fragment
is then isolated according to ~nown procedures and
stored for subsequent ligation.
B. Ligation
About 20 ~g. of the partial BclI digest of
plasmid pNM702A (prepared in Example 12B) and about
10 1~g. of the plasmid pBR322 DNA with BclI sticky
Z~9
X-5910 -41-
termini are ligated in substantial accordance with the
teaching of Example 2C. The resultant DNA is washed
twice in 70% ethanol, dried ln vacuo and suspended in
TE buffer.
Recombinant plasmids of two orientations re-
sult depending upon the orientation of the inserted
pBR322 fragment. Plasmid pNM708A designates the re-
combinant plasmid in which the sub-terminal HindIII
restriction site of the pBR322 fragment is inserted
10 closest to flanking SacI site of plasmid pNM702A.
Plasmid pNM708B designates the recombinant plasmid with
the reverse orientation. In addition, the insertional
isomers of plasmids pNM708A and pNM708B are also pro-
duced since plasmid pNM702A has two BclI restriction
15 sites for the insertion of the pBR322 fragment. A
restriction site map of each of plasmlds pNM708A and
pNM708B is presented in Figure 6 of the accompanying
drawings.
Example 21
Construction of E. coli K12 HB101/pNM708A
and E. coli K12 HB101/pNM708B .
The desired constructions are made in sub-
stantial accordance with the teaching of Example 3 ex-
cept that plasmid DNA from Example 20B, rather than
plasmid pLR2, is used for the transformation. Surviv-
ing colonies are first selected, tested for the ex-
pected phenotype ~AmpR, TetS) and then conventionally
30 identified as the desired E. coli K12 HB101/pNM708A and
_. coli K12 HB101/pNM708B transformants by restriction
X-5910 -42-
enzyme and agarose gel electrophoretic analysis of the
constitutive plasmids (Wieslander, 1979). The trans-
formant cultures a~re used for subsequent production and
isolation of their respective plasmids.
~xample 22
Cons-truction of Streptomyces ambofaciens/pNM708A and
-
S. ambofaciens/pNM708B
The desired constructions are made in sub-
stantial accordance with the teaching of ~xample 9 e~-
cept that DNA from Example 20, rather than plasmids
ENL~702A and pNM702B, is used for the transformation.
The resulting transformants are selected for thio-
lS strepton resistance by the method described in Exam-
ple 9 above. The thus constructed thiostrepton resis-
tant Streptomyces ambofaciens/pNM708A and S. ambo-
faciens/pNM708B colonies are isolated according to
known procedures and then ~on~-entionally identified by
restriction enzyme and electrophoretic analysis of the
cons~itutive plasmids (Weislander, 1979).
Representative plasmids and transformants
constructed in accordance with the foregoing teaching
include the following listed in Tables 1 and 2 below.
X-5910 -43-
~ 3 ~h 3 0 ~ O ~
a~ o,~o ~:: o ~1 o .4
~H ~ ~~ ~ ~ V t)
1~ U~ I H ~ I 1-1
o tn o u~ ~)
O U~ O
, ~ m ~,
t~ ~ o ~ ~ o
u~
U~ o
a
,Y o ,1 ~ ~
~) ,y ~) ~ o. ~ O ~ o
-,~ ~ O ~ ~1
t~ o ~ o
~ ~1 ~ H ~)
o o ~ o ~ ~ v ~ I` ~ ~ a) ~
,1 ~o a~ ~o v ~m ~o ~ .,,0
r` ~ h 0 1-- h ~ 1`
~1 Z cr~ H Z O ~ ~1 Z ~--1
~1 ~C ~ ~1 0 ~ l H rl O ~ ~I H
u~ ~ E~ O ~ O 1` ~1 3 1_ ~1
~5 U~ (~ ~ 5~ t~ ~ ~ ~ ~ ~ ~
.,~ ~ m 1 ~ z m ~ ~ z cn ~ ,1 æ u~ ~ z
~ o ~ oP~ ~ o ~ ~ ~ Q a) o
u~ ~ Q u~
~ ,y ~ ~~ ~ ~ ~ ~ ~ ~ o f~
,~ ~1 ~O ~1 ~ o ~ 1- 0 ~ Z o
~ e ~ ~ ~ ~~r ~ ~ ~ o ~: a) ~ o ~ a~
L ~ ~1
a) ~7 o ~ ~:o ~- o a~ ,¢ o ~ Q.. Ql ~ O ~ 5 0
Q) ~? ~)~rl u) ~rlc~ ~rl \D ~rl
r-l ~1~: ~ O ~ l O
.R ~J~V rl O [~ (1~ l o 1
tt~ a~ rC
E-l ~)~) ~ Z ~ ~ ~) Z
~:~ Q, a) ~ s~ a) ~ ~ o ~ ~ a
u~ O E3 ~ 5~0 E~ ~ ~O ~ Q~ o h ~
G) ~1 ~U r10 t~ l 0 ~1 0 4-1 (1) 0
~1
Q' o 5~ a) o ~ o t5' a~ ~ O
1:~ .~ ~ r~ ~~ rl V ~; ~1 ~ rl Sl e S~
~ ~ e ~ ~ ~ e ~
~ ~r~ ~ X
N r4 ~ ~ ~ ~ t`l~`I ~ ~r
~rl X
r~
m ~ m ~ m
~ a~ o o ~ ~ ~ ~
e ~ o o ~ ~ ~ ,~
Z ~
z z z z z z æ z
ç~ Q, ~ Q, Q, ~ Q,
3 0 ~3
Q,
e o ~ ~ Ln ~0 1~ cO ~ o
X
r~
g
X-5910 -44-
~ .
r~
al ~ H
Q~ 0 a.~ H V
O
~ ~ ~ ~ Q) .¢ ~
0 s~ o ~ o ~0 r` C
~ a) 0 ~ a o
0
C ~ ~Z ~ ~Z
H L ,~
O 0~ 0~ 0
a~ o o
~ m s~ o ~
C ~ ~ X
a) o 3)
1` ~ O ~ O
o ~ z a~
.,~ h ~ ~ h ~ c~
~ H O ~1 ~ H C ~ H ~ 1--1 ~1 S
5~ 5~ ~1 ~I X H L)~ X H ~1 5
~ ~ ~I~ Q ~ IVIR
~ m x z~ m m o ~ m m x m 1
. 0 O Q ~ Q R C Q Q ~ Q C -
. ~ XX 0~ ~ X~ . XQ 0~
_ ~ . 5~ U~ O rl C~ O U~ X~
o ~ r ~ o
~ ~ r C
o a)u~ H ~ O~r ~`I ~) ~ O ~
;) ~c~ ~ ~ ~ I C Z ~rl c' ~1 S c~ a~ C Z
.~ O ~ ~ c~ aJ Q~ ~ c~ ~ ,? a) Q.
-1 ~ ~ ,~
d S ~ ~) ~: a~ h C ~ ~C ~) ~ S a~ 5~ C
~ ~ ~ Q O C ~ S O 1 ~ ~ ~ O ~ ~ O r
Q aC)X ~ C ~ ~ 0
~ u~o a~ o s~ o ~ c ~~ o ~ o ~ o ~ C
E~ ~ c~ O C ~ O C~
51 ~ c ~ ~ o
~O O ~ f~ O O C O O ~o i::
a~ ,~ O ~ I ~ O ~a
~: O ~ Z ~ ~ rl ~.q
,1 ~ ~ æ ~ ,1 m ~ rl m 5~ c ,1 m ~ ~
~ ~d O ~ ~ ; ~ ~o .,1 ~ ~ 0
t~ Q ~r
~l X . ~r ~ ~ o o
C ~ ~ ~ ~ ~"
m ~ m
Z
~ Z Z Z ~ Z Z
3 0
~ O ~~ ~ ~ U~
;~ Z ~ ~ ~ r~
X-5910 -45-
H I I U~ I
x o
~ S~
I ~ CO ~ ~ V
~ ~ ~ o m ~
" ~
E~ ~ a) .{: Q ? ~) H E~ ~: H 0
~ X
,1 ~ ~ ~ ~ o ~ ~ s~ ~ m
~z ~ ~ ~m ~ ~ s~
a
? ~ ~ ~ .q ~ ~
o ~ .4 o ~ a) ~ rY ~Y Q
o x ~ ~ a) ~ . H CO ,Y
~) ~ H ~ C~ ~1 .
o ~ a) ~ ~ t) . .? a~
m
~ ~ ~ ? u~ I H ,~:
O ~ ~ O ~ ~ H a~ a)O ~ a)
1 0 ,1 ~ o ~ ,5~ ~:
O ~ ~ ~ ~ ~
~1 H Ul ~ ,4 (~ ~1 0
~~C H ~1 ~1 r~ a~ rl ~ C O I--I ,Y O ~1
U~ ~)~ ~1 O ~I t) X ~ 1` ` 1-
~ ul~ {~ a) h X ~ æ U U~ c æ
,~ cm m c ~ ~ o ~ z ~ o z
OO rl
.U~ V.4 ,4 ~1 Ul C ~~ o
O 1~
_~1 ~I H ~ .Y ~ æ O rl ~ ~ O
15 ~P~oo ~r ~ ~ I t~ C Z ~O
~ . . U~ ~ ~
OC)~ (~I C P~ ~ z~ 1 o ~ H rl æ o
~ ~ ? ~ rl ~ ~ ~ m ~ ~ ~ rl ~,, s~ z ~'
rl ? a) ~ U~ QJ H O-~l ~) O O Q~
,1 ~ ~ m
ta ~ tV C ~ u~ ~ ,C S: tn ~ .C C
O ~ ~ .~:: ta ~1 ~ ~ O ~\ (a t~ C ~ S -rl 1~
~ C~ ~ tn u~ m ~ a) ~ t.~ tl)
R tv ~ ~ tt~ tV ,a ~ ~ ~ ~; ~ .,, ~ ,1~ tn ~
t~ 0 O ~ O S h ~1 0 ~: O S ~ Ei h 0 3 ~ ~ h
E~ ~ C rl ~ R. tl) ~ ta O Q~ O
h ~: al ~ C ~ ~ ~: rl 0 t~
~ O ~ ~ O ~ ~ 0 3 ~ a)
tl~ . rl o~ t~ tV ttS rl O ~V tn rl ~1 0 t~ 0
; ~ ~ n h
n~ tY~ tV tn tD tV ~ D ~ ~) tV ~ :~ ~ Q)
t~ t~ C ::~ ~ O
~1 ~ h tn ~ta h R ~H~ tQ a~ rl h tV
~ ~O rl tn U~ ~ ~ tr .
(D Lr~ Lr')
N R ~ I_ ~n a~ In Lr
r~ ~
U~ ~ O O O Lr) L~)
C ~ ~ ~ ~
m ~ m
rl ~ I~ ~ a~ o~ o o
~ z æz ~ æz æz æ æz
~ p~ ~ ~ ~ ~ ~
3 0
s o r~ co ~ o
X ~ ~ ~
~2~
X-5910 -46-
Table 2
Representative Transformants
1. Streptomyces R/R wherein R is ambofaciens,
aureofaciens, griesofuscus, fradiae, lividans,
lividans 1326, granuloruber, tenebrarius or
cinnamonensis and wherein Rl independently is
plasmid pNM702A, pNM702B, pNM704A, pNM704B,
pNM705A, pNM705B, pWM703A, pNM703B, pNM706A,
pNM706B, pNM707A, pNM707B, pNM708A, pNM708B
or any plasmid listed in Table 1.
2. E. coli R2/R3 wherein R2 is K12 or K12 HB101
and wherein R3 independently is plasmid
pNM708A, pNM708B, pNM713A, pNM713B, pNM714A,
pNM714B, pNM71$A, pNM716A, pNM716B or pNM718A.
-
